An Open-label Phase I/II Study of KX2-391 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs KX 01 (Primary) ; Paclitaxel
- Indications Advanced breast cancer; Gastric cancer; Solid tumours
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 15 Jan 2013 New source identified and integrated (ClinicalTrials.gov record NCT01764087).
- 07 Jan 2013 Planned End Date changed to 1 May 2016, as reported by ClinicalTrials.gov.